Advancing oncology drug development: Innovative approaches to enhance success rates while reducing animal testing.

Drug development remains a high-risk endeavour, particularly in oncology, where failure rates exceed 90 %. This review examines emerging tools and strategies designed to enhance preclinical success rates, aligning with the 3Rs principle: Reduction, R…

Preview only. Read the full abstract at the source